LNTH vs PHG vs PRE Stock Comparison

Lantheus Holdings, Koninklijke Philips and Prenetics Global Prices as of Oct 27, 2026 Peers: Industry group
1 more company in this comparison (BFLY) Create a free account to keep reading and compare up to 10 companies.
LNTH Lantheus Holdings, Inc.
$100.15 +0.4% 1M +72.3% 1Y
Market cap
$6.53B
P/E
23.7x
Revenue (TTM)
$1.56B
Div. yield
–
Diagnostic Equipment Healthcare
6 wins
PHG Koninklijke Philips Nv
$26.42 +5.8% 1M -8.5% 1Y
Market cap
$25.70B
P/E
13.9x
Revenue (TTM)
$20.60B
Div. yield
–
Diagnostic Equipment Healthcare
4 wins
PRE Prenetics Global Ltd
$18.43 -19.8% 1M +40.9% 1Y
Market cap
$264.04M
P/E
–
Revenue (TTM)
$185.92M
Div. yield
–
Diagnostic Equipment Healthcare
1 win

Head to Head

11 decided of 12

Lantheus Holdings leads on 6 of the 12 questions below (Lantheus Holdings 6, Koninklijke Philips 4, Prenetics Global 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionLNTHPHGPRELeader
Larger companyMarket capitalisation $6.53B $25.70B $264.04M PHG
Cheaper on earningsLower P/E, profitable companies only 23.7x 13.9x -3.7x PHG
Cheaper on forward earningsLower price / next fiscal year consensus EPS 17.4x 13.3x — PHG
Faster revenue growthRevenue growth, trailing twelve months +2.3% +6.1% +513.0% PRE
More profitableNet margin, trailing twelve months 17.7% 8.9% -38.2% LNTH
Better return on capitalReturn on invested capital 12.5% 11.5% — LNTH
Less leveragedLower net debt / EBITDA -0.1x 1.8x — LNTH
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +72.3% -8.5% +40.9% LNTH
Better 5-year returnAnnualised price return, 5 years +34.4%/yr -11.1%/yr -30.7%/yr LNTH
Less volatileAnnualised volatility, 1 year 32.3% 28.7% 81.0% PHG
Higher overall scoreMean of the five percentile scores vs peers 80/100 80/100 51/100 LNTH

Percentile Scorecard

LNTHPHGPRE

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisLNTHPHGPRE
Valuation 80 #46 of 227 98 #6 of 227 35 #148 of 227
Growth 63 #82 of 219 95 #11 of 219 68 #70 of 219
Profitability 94 #13 of 206 95 #11 of 206 43 #118 of 206
Financial Health 69 #74 of 238 31 #165 of 238 57 #102 of 238
Shareholder Returns 93 #11 of 134 79 #29 of 134 –
Overall 80 80 51
  • LNTH ranked among 247 companies in Medical Devices and Diagnostics
  • PHG ranked among 247 companies in Medical Devices and Diagnostics
  • PRE ranked among 247 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodLNTHPHGPRESPY
1 month +0.4%+5.8%-19.8% -0.2%
3 months -2.4%+3.4%+0.9% +3.9%
6 months +19.9%-2.6%+0.3% +8.2%
Year to date +50.5%-2.4%+17.0% +12.9%
1 year +72.3%-8.5%+40.9% +12.3%
3 years +49.9%+42.8%+228.9% +87.4%
3 years, per year +14.4%+12.6%+48.8% +23.3%
5 years +337.5%-44.3%-84.0% +67.9%
5 years, per year +34.4%-11.1%-30.7% +10.9%
10 years +1,092.3%-11.3%— +261.1%
10 years, per year +28.1%-1.2%— +13.7%

Risk

MeasureLNTHPHGPRESPY
Volatility, 1Y 32.3%28.7%81.0% 12.7%
Downside volatility, 1Y 27.5%28.7%74.2% 12.7%
Beta vs S&P 500, 1Y 0.590.811.52 1.00
Return / volatility, 1Y 2.24-0.300.50 0.97
Max drawdown, 5Y -59.5%-75.6%-97.6% -25.4%
From 52-week high -9.7%-19.7%-29.8% -1.2%
52-week high $110.94$32.91$26.25 $779.14
52-week low $50.69$23.81$11.79 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleLNTHPHGPRE
P/E now vs peer median 23.7xmedian 29.6x 13.6xmedian 29.6x -3.6xmedian 29.6x
P/S now vs peer median 4.2xmedian 2.9x 1.2xmedian 2.9x 1.7xmedian 2.9x
EV/EBITDA now vs peer median 16.5xmedian 17.4x 8.1xmedian 17.4x -4.2xmedian 17.4x
P/FCF now vs peer median 16.9xmedian 22.3x 5.9xmedian 22.3x -6.0xmedian 22.3x
P/B now vs peer median 5.0xmedian 2.3x 1.9xmedian 2.3x 3.3xmedian 2.3x
PEG now vs peer median 0.22median 1.04 0.32median 1.04 -0.07median 1.04

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsLNTHPHGPRE
Revenue $1.56B $20.60B $185.92M
Gross profit $936.02M $16.03B $88.89M
Operating income $302.34M $2.65B -$61.83M
Net income $275.31M $1.39B -$71.99M
Free cash flow $387.83M $4.34B -$51.49M
R&D $173.09M $2.00B $4.11M
EPS (diluted) $4.08 $1.91 $-5.06
Cash & equivalents $593.30M $2.04B $59.05M
Total debt $571.05M $9.51B –
Shares (diluted) 67.52M 962.50M 14.05M
Enterprise value $4.70B $14.81B $127.86M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricLNTHPHGPRE
P/E 23.7x 13.6x -3.6x
P/FCF 16.9x 5.9x -6.0x
P/Operating cash flow 15.8x 9.6x -6.0x
P/S 4.2x 1.2x 1.7x
P/B 5.0x 1.9x 3.3x
P/Tangible book 10.5x 2.5x 3.3x
EV/EBITDA 16.5x 8.1x -4.2x
EV/EBIT 21.5x 12.4x -4.1x
EV/Revenue 4.2x 1.6x 1.4x
EV/FCF 16.8x 7.6x -4.9x
EV/Operating cash flow 15.8x 12.4x -4.9x
PEG (3Y EPS CAGR) 0.22 0.32 -0.07

Growth

14 metrics
MetricLNTHPHGPRE
Revenue growth (1Y) 2.3% 6.1% 513.0%
Revenue CAGR (3Y) 11.4% 2.3% 115.5%
Gross profit growth (1Y) -3.4% 82.4% 413.6%
Gross profit CAGR (3Y) 16.3% 6.7% 127.9%
Operating income growth (1Y) -30.9% 121.3% -49.2%
Operating income CAGR (3Y) 118.8% 52.0% -1.9%
Net income growth (1Y) 1.6% 293.5% -60.1%
Net income CAGR (3Y) 102.1% 35.6% -16.5%
EPS growth (1Y) 5.8% 539.4% -28.5%
EPS CAGR (3Y) 105.5% 42.2% 52.8%
Operating cash flow growth (1Y) -21.7% 116.7% –
Operating cash flow CAGR (3Y) 14.5% 53.6% –
Free cash flow growth (1Y) -10.1% 54.2% –
Free cash flow CAGR (3Y) 103.0% 45.6% –

Profitability

14 metrics
MetricLNTHPHGPRE
Gross margin 60.1% 77.8% 47.8%
EBITDA margin 25.4% 19.8% -32.6%
Operating margin 19.4% 12.9% -33.3%
Pretax margin 23.3% 11.9% -24.2%
Net margin 17.7% 8.9% -38.2%
FCF margin 24.9% 21.1% -27.7%
Operating cash flow margin 26.5% 12.9% -27.7%
Return on equity 21.8% 12.7% -67.3%
Return on assets 11.6% 5.4% -43.8%
Return on invested capital 12.5% 11.5% –
Return on capital employed 14.8% 11.8% -48.3%
Asset turnover 0.7x 0.7x 1.1x
Cash conversion (OCF / net income) 1.5x 1.9x 0.7x
Stock comp / revenue 5.0% 0.7% 3.4%

Financial Health

11 metrics
MetricLNTHPHGPRE
Debt / assets 23.6% 31.2% –
Debt / equity 0.4x 0.7x –
Net debt / EBITDA -0.1x 1.8x –
Debt / FCF 1.5x 2.2x –
Liabilities / assets 45.7% 57.1% 39.5%
Equity / assets 54.3% 42.9% 60.5%
Interest coverage 15.3x 6.2x –
Current ratio 3.1x 1.3x 4.0x
Quick ratio 2.8x 0.7x 1.8x
Cash ratio 1.8x 0.2x 1.6x
Altman Z-score 5.46 – –

Shareholder Returns

7 metrics
MetricLNTHPHGPRE
Dividend yield – 3.7% –
Net buyback yield 2.9% -0.5% –
Shareholder yield 2.9% 3.3% 0.0%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusLNTHPHGPRE
Forward P/E 17.4xFY2026 13.3xFY2026 –
EPS, next fiscal year $5.76FY2026 $1.98FY2026 $-3.42FY2026
EPS growth, next FY -5.3%FY2026 +6.5%FY2026 –
EPS growth, the year after +4.2% -10.1% –
Revenue, next fiscal year $1.57BFY2026 $21.63BFY2026 $234.43MFY2026
Revenue growth, next FY +1.8%FY2026 +1.8%FY2026 +153.7%FY2026
Revenue growth, the year after +12.7% -8.2% +65.3%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersLNTHPHGPRE
Held by institutions 100.0% 5.4% 0.9%
Institutions holding 465 363 1
Change in shares held, QoQ +3.4% +0.8% –
Institutions buying 248 266 0
Institutions selling 142 76 0
Buyers to sellers 1.75 3.50 –

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

LNTHPHGPRE
LNTH 1.00 0.19 0.09
PHG 0.19 1.00 0.08
PRE 0.09 0.08 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, LNTH, PHG and PRE?

Koninklijke Philips (PHG) is the largest by market capitalisation: Lantheus Holdings (LNTH) $6.53B, Koninklijke Philips (PHG) $25.70B, Prenetics Global (PRE) $264.04M.

Which stock is cheaper, LNTH, PHG and PRE?

Koninklijke Philips (PHG) trades on the lowest price-to-earnings ratio (Lantheus Holdings (LNTH) 23.7x, Koninklijke Philips (PHG) 13.9x, Prenetics Global (PRE) -3.7x). On next year's consensus earnings, Koninklijke Philips (PHG) is cheapest (Lantheus Holdings (LNTH) 17.4x, Koninklijke Philips (PHG) 13.3x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Prenetics Global (PRE) grew revenue fastest over the trailing twelve months: Lantheus Holdings (LNTH) +2.3%, Koninklijke Philips (PHG) +6.1%, Prenetics Global (PRE) +513.0%.

Which company is more profitable?

Lantheus Holdings (LNTH) has the highest net margin (Lantheus Holdings (LNTH) 17.7%, Koninklijke Philips (PHG) 8.9%, Prenetics Global (PRE) -38.2%). On return on invested capital, Lantheus Holdings (LNTH) leads (Lantheus Holdings (LNTH) 12.5%, Koninklijke Philips (PHG) 11.5%).

Which stock has performed better?

Over the past year Lantheus Holdings (LNTH) returned the most: Lantheus Holdings (LNTH) +72.3%, Koninklijke Philips (PHG) -8.5%, Prenetics Global (PRE) +40.9%. Over five years, Lantheus Holdings (LNTH) compounded fastest (Lantheus Holdings (LNTH) +34.4%/yr, Koninklijke Philips (PHG) -11.1%/yr, Prenetics Global (PRE) -30.7%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Koninklijke Philips (PHG) has been the steadiest (Lantheus Holdings (LNTH) 32.3%, Koninklijke Philips (PHG) 28.7%, Prenetics Global (PRE) 81.0%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, LNTH, PHG and PRE?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Lantheus Holdings (LNTH) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.